Header Logo

Julio Morales

Concepts (180)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
DNA Repair
11
2020
81
1.560
Why?
Exoribonucleases
3
2022
20
1.490
Why?
Brain Neoplasms
2
2022
297
1.160
Why?
DNA Damage
10
2020
149
1.010
Why?
Glioblastoma
1
2022
101
0.720
Why?
Cell Cycle Proteins
5
2018
185
0.720
Why?
Neoplasm Proteins
4
2020
123
0.720
Why?
DNA Polymerase I
1
2020
1
0.700
Why?
Tumor Suppressor p53-Binding Protein 1
5
2016
6
0.680
Why?
Genomic Instability
5
2020
33
0.670
Why?
Up-Regulation
1
2020
241
0.640
Why?
Poly(ADP-ribose) Polymerases
3
2020
22
0.640
Why?
Glioma
1
2020
117
0.630
Why?
Phosphoproteins
5
2006
116
0.620
Why?
DNA Replication
2
2020
49
0.560
Why?
Intracellular Signaling Peptides and Proteins
5
2006
280
0.530
Why?
Transcription, Genetic
1
2016
401
0.460
Why?
Transcription Termination, Genetic
1
2014
1
0.450
Why?
Neoplasms
4
2016
768
0.430
Why?
Gene Expression Regulation, Neoplastic
4
2020
446
0.420
Why?
DNA Breaks, Double-Stranded
4
2020
24
0.360
Why?
DNA-Binding Proteins
8
2020
481
0.350
Why?
Cell Movement
2
2022
353
0.330
Why?
Mice
10
2022
4478
0.290
Why?
Animals
12
2022
10093
0.280
Why?
Tumor Suppressor Protein p53
3
2008
99
0.280
Why?
Carrier Proteins
3
2004
246
0.280
Why?
Thymus Neoplasms
1
2006
8
0.260
Why?
Humans
18
2022
27160
0.260
Why?
Lymphoma
1
2006
22
0.260
Why?
Cell Line, Tumor
6
2020
1271
0.250
Why?
Radiation-Sensitizing Agents
2
2016
32
0.240
Why?
Breast Neoplasms
2
2020
448
0.230
Why?
Naphthoquinones
2
2014
11
0.220
Why?
HeLa Cells
4
2020
206
0.220
Why?
DNA Mismatch Repair
2
2016
12
0.210
Why?
RNA Helicases
3
2020
8
0.210
Why?
Chromosome Aberrations
1
2003
36
0.210
Why?
Neoplastic Processes
1
2022
4
0.200
Why?
RNA, Neoplasm
1
2020
24
0.180
Why?
Nuclear Proteins
3
2014
245
0.180
Why?
Poly (ADP-Ribose) Polymerase-1
1
2020
8
0.180
Why?
Mutation
3
2018
820
0.180
Why?
Antineoplastic Agents
3
2016
660
0.180
Why?
Etoposide
1
2020
19
0.170
Why?
Radiation, Ionizing
1
2020
25
0.170
Why?
Indazoles
1
2020
16
0.170
Why?
Transcription Factors
2
2014
512
0.170
Why?
RNA, Messenger
1
2022
648
0.170
Why?
Piperidines
1
2020
45
0.170
Why?
Survival Analysis
1
2020
278
0.160
Why?
DNA End-Joining Repair
2
2020
3
0.160
Why?
Cell Proliferation
1
2022
775
0.160
Why?
Genes, BRCA2
1
2018
9
0.150
Why?
Genes, BRCA1
1
2018
11
0.150
Why?
Proto-Oncogene Proteins c-abl
2
2008
3
0.150
Why?
Intracranial Aneurysm
1
2019
55
0.150
Why?
Stents
1
2019
116
0.150
Why?
Cells, Cultured
2
2014
978
0.140
Why?
Cell Nucleus
2
2016
135
0.140
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2018
33
0.140
Why?
Disease Models, Animal
3
2018
1406
0.140
Why?
MicroRNAs
1
2020
281
0.140
Why?
Neurosurgical Procedures
1
2019
215
0.130
Why?
Multifunctional Enzymes
1
2016
1
0.130
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2016
8
0.130
Why?
Plasmids
1
2016
122
0.130
Why?
Proto-Oncogene Proteins p21(ras)
1
2016
60
0.130
Why?
DNA Helicases
1
2016
51
0.130
Why?
Microscopy, Fluorescence
1
2016
163
0.120
Why?
Genomics
1
2016
116
0.120
Why?
RNA, Small Interfering
1
2016
195
0.120
Why?
Protein Structure, Tertiary
2
2014
283
0.120
Why?
Chromosomal Proteins, Non-Histone
3
2006
77
0.120
Why?
Mice, Knockout
4
2006
795
0.120
Why?
Quinones
1
2014
23
0.110
Why?
NAD(P)H Dehydrogenase (Quinone)
1
2014
40
0.110
Why?
Endonucleases
1
2014
17
0.110
Why?
Bystander Effect
1
2014
16
0.110
Why?
Histones
2
2006
90
0.110
Why?
Triple Negative Breast Neoplasms
1
2014
36
0.110
Why?
Necrosis
1
2014
82
0.110
Why?
Nanomedicine
1
2014
62
0.100
Why?
Enzyme Inhibitors
1
2014
247
0.100
Why?
Saccharomyces cerevisiae Proteins
1
2014
110
0.100
Why?
Molecular Targeted Therapy
1
2014
129
0.100
Why?
Lung Neoplasms
1
2016
342
0.100
Why?
Epigenesis, Genetic
1
2014
146
0.100
Why?
Xenograft Model Antitumor Assays
3
2018
251
0.090
Why?
G2 Phase
3
2008
15
0.090
Why?
Repressor Proteins
2
2016
114
0.090
Why?
Synthetic Lethal Mutations
2
2020
4
0.080
Why?
Fluorouracil
1
2009
53
0.080
Why?
Antimetabolites, Antineoplastic
1
2009
46
0.080
Why?
A549 Cells
2
2020
16
0.080
Why?
Tumor Suppressor Proteins
1
2008
49
0.070
Why?
Immunoglobulin Class Switching
2
2006
9
0.070
Why?
Adaptor Proteins, Signal Transducing
1
2008
161
0.070
Why?
Chromosomes, Mammalian
1
2006
6
0.070
Why?
Protein-Arginine N-Methyltransferases
1
2005
3
0.060
Why?
Cytosol
1
2006
47
0.060
Why?
Phosphorylation
2
2004
568
0.060
Why?
Female
6
2020
14661
0.060
Why?
Cell Transformation, Neoplastic
1
2006
114
0.060
Why?
Survival Rate
1
2006
411
0.060
Why?
Apoptosis
1
2008
740
0.060
Why?
X-ray Repair Cross Complementing Protein 1
1
2004
1
0.060
Why?
Immunoglobulin Constant Regions
1
2004
3
0.060
Why?
Casein Kinase II
1
2004
17
0.060
Why?
Mice, Nude
2
2016
313
0.060
Why?
Carcinoma, Renal Cell
1
2004
75
0.060
Why?
Kidney Neoplasms
1
2004
98
0.050
Why?
Terminal Repeat Sequences
1
2003
2
0.050
Why?
Active Transport, Cell Nucleus
1
2003
17
0.050
Why?
Growth
1
2003
24
0.050
Why?
BRCA1 Protein
1
2003
23
0.050
Why?
Genome
1
2003
52
0.050
Why?
Mitosis
1
2002
109
0.050
Why?
Models, Biological
3
2009
448
0.050
Why?
Tomography, X-Ray Computed
1
2004
466
0.050
Why?
Autoimmune Diseases
1
2003
162
0.050
Why?
Epithelial-Mesenchymal Transition
1
2020
110
0.040
Why?
HEK293 Cells
1
2020
176
0.040
Why?
Angiography, Digital Subtraction
1
2019
19
0.040
Why?
CDC2 Protein Kinase
1
2018
15
0.040
Why?
Endovascular Procedures
1
2019
61
0.040
Why?
Equipment Design
1
2019
212
0.040
Why?
Genes, Reporter
1
2018
87
0.040
Why?
Signal Transduction
3
2009
1379
0.040
Why?
Promoter Regions, Genetic
1
2018
331
0.030
Why?
Dose-Response Relationship, Drug
2
2008
589
0.030
Why?
Follow-Up Studies
1
2019
989
0.030
Why?
DNA Topoisomerases, Type I
1
2016
7
0.030
Why?
RNA Polymerase II
1
2016
7
0.030
Why?
Ku Autoantigen
1
2016
12
0.030
Why?
Antigens, Nuclear
1
2016
22
0.030
Why?
RNA Interference
1
2016
135
0.030
Why?
Multiprotein Complexes
1
2016
53
0.030
Why?
Protein Kinase Inhibitors
1
2016
143
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2016
103
0.030
Why?
Postoperative Complications
1
2019
606
0.030
Why?
Aged, 80 and over
1
2019
1944
0.030
Why?
Aged
2
2019
5231
0.030
Why?
Tumor Cells, Cultured
1
2014
310
0.030
Why?
B-Lymphocytes
2
2006
278
0.030
Why?
Oxidation-Reduction
1
2014
355
0.030
Why?
Treatment Outcome
1
2019
2286
0.030
Why?
Middle Aged
2
2019
6913
0.020
Why?
MutL Protein Homolog 1
1
2008
1
0.020
Why?
Tumor Protein p73
1
2008
2
0.020
Why?
Methylnitronitrosoguanidine
1
2008
2
0.020
Why?
Base Pair Mismatch
1
2008
7
0.020
Why?
Cytoplasm
1
2008
57
0.020
Why?
Imatinib Mesylate
1
2008
12
0.020
Why?
Benzamides
1
2008
33
0.020
Why?
Male
2
2019
13040
0.020
Why?
Models, Genetic
1
2008
123
0.020
Why?
Piperazines
1
2008
45
0.020
Why?
Cell Cycle
1
2008
155
0.020
Why?
Pyrimidines
1
2008
121
0.020
Why?
Colonic Neoplasms
1
2008
116
0.020
Why?
Chromosome Breakage
1
2006
1
0.020
Why?
Immunoglobulin Heavy Chains
1
2006
10
0.020
Why?
Cytidine Deaminase
1
2006
7
0.020
Why?
Methylation
1
2005
21
0.020
Why?
Translocation, Genetic
1
2006
22
0.020
Why?
Biopolymers
1
2005
14
0.020
Why?
In Situ Hybridization, Fluorescence
1
2006
72
0.020
Why?
Arginine
1
2005
39
0.020
Why?
Glycine
1
2005
31
0.020
Why?
In Vitro Techniques
1
2006
240
0.020
Why?
Recombination, Genetic
1
2005
62
0.020
Why?
Stem Cells
1
2005
113
0.010
Why?
Amino Acid Sequence
1
2005
679
0.010
Why?
Molecular Sequence Data
1
2005
1041
0.010
Why?
Checkpoint Kinase 2
1
2002
3
0.010
Why?
Protein Kinases
1
2002
147
0.010
Why?
Cell Line
1
2002
683
0.010
Why?
Gene Expression Regulation
1
2002
626
0.010
Why?
Retrospective Studies
1
2004
2453
0.010
Why?
Morales's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (180)
Explore
_
Co-Authors (2)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_